I’d like to know your point of view about why this biotech closed end fund, in existence for more than 20 years, has reached a record of average discount of more than 15-20% for the last 10 years.
Any idea why?
Hera are some data.
- Inception date: Nov 1993
- Price and discount, 20 years:
- Total Expense Ratio
- Number of shares outstanding:
- Lat 3 weeks of Nav and Price
- Lat 3 weeks of volumes: